March 13, 2023Cardiology JournalOpen Access

Flecainide in clinical practice

View Full Paper

Ask AI

Bookmark

Why the study?

Despite its long clinical presence and recent availability in Poland, flecainide distribution across Europe has been unequal, warranting a review of its clinical uses and practical management.

Design

Review

Authors

MBMikołaj BaszaMedical University of Silesia CMCezary MaciejewskiMedical University of Warsaw WBWojciech BojanowiczMedical University of Silesia

Discussion

Member takes

Implication

May aid flecainide selection and monitoring; leaves open need for updated RCTs versus newer agents.

Structured PICO

Population

Patients with cardiac arrhythmias (including paroxysmal supraventricular tachycardias, atrial fibrillation, AVNRT, AVRT, and ventricular arrhythmias) without structural heart disease, as well as children and pregnant women.

Intervention

Flecainide

This review provides a comprehensive overview of flecainide's clinical applications, emphasizing its utility in treating various arrhythmias in patients without structural heart disease, including special populations like children and pregnant women.

Cite This Study

Basza et al. (2023) studied this question.

synapsesocial.com/papers/69ffcc58d1d8b50f8e9a117b https://doi.org/10.5603/cj.a2023.0018

Topics

Persistent AF management Atrial fibrillation Ventricular arrhythmias

View Full Paper

Ask AI

Bookmark

Flecainide in clinical practice

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Flecainide in clinical practice

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider